Quantcast
Last updated on April 17, 2014 at 17:30 EDT

NaphCare, Inc. Continues Partnership with Wende and Fishkill Correctional Facilities

December 16, 2012

NaphCare, Inc., a Birmingham, AL based independent provider of comprehensive correctional healthcare and corrections-based technology services, was re-awarded a (5) five-year contract to provide correctional dialysis services with the New York Department of Corrections and Community Supervision (NYDOCCS) effective January 1, 2013. The contract includes services at two facilities: Wende Correctional Facility located in Alden, NY, and Fishkill Correctional facility located in Beacon, NY.

Birmingham, AL (PRWEB) December 15, 2012

In total, NaphCare has been a partner with the NYDOCCS for nearly 20 years. Each partnership began with the start of each facility; Fishkill in 1995 and Wende in 2000. Both facilities are part of the NYDOCCS, together housing an average population of 2600 inmates.

“Continuing a successful partnership with the NYDOCCS is exemplary of all the devoted, hard-working professionals on both NaphCare and NYDOCCS´s team that serve at the Fishkill and Wende facilities,” says Rick Apollo, Vice-President of Ancillary Services. “Many team members have been with NaphCare since the beginning of these agreements and it is that type of commitment we can attribute our success. We value the relationships and look forward to continuing our philosophy of providing excellent dialysis services.”

NaphCare, Inc., is the leading provider of on-site correctional dialysis services and has provided nephrology services to county, state, and federal correctional facilities across the country. Services include hemodialysis, peritoneal dialysis, inpatient management, and nephrology consultations.

About NaphCare

Since 1989, NaphCare has been managing a full range of healthcare programs for correctional facilities throughout the country, providing quality, proactive care through creative solutions and innovative technology.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/12/prweb10238494.htm


Source: prweb